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ABSTRACT
Amplification and overexpression of CHD1L is one of the most frequent genetic 
alterations in hepatocellular carcinoma (HCC). Here we found that one of CHD1L 
downstream targets, NTKL, was frequently upregulated in HCC, which was significantly 
correlated with vascular invasion (P = 0.012) and poor prognosis (P = 0.050) of HCC. 
ChIP assay demonstrated the binding of CHD1L to the promoter region of NTKL. 
QRT-PCR study showed that the expression of NTKL positively correlated with CHD1L 
expression in both clinical samples and cell lines. Functional study found that NTKL 
had strong oncogenic roles, including increased cell growth, colony formation in 
soft agar, and tumor formation in nude mice. Further study found that NTKL could 
promote G1/S transition by decreasing P53 and increasing CyclinD1 expressions. 
NTKL overexpression could accelerate the mitotic exit and chromosome segregation, 
which led to the cytokinesis failure and subsequently induced apoptosis. NTKL also 
regulated cell motility by facilitating philopodia and lamellipodia formation through 
regulating F-actin reorganization and the phosphorylation of small GTPase Rac1/
cdc42. Using co-IP and mass spectrometry approach, we identified the large GTPase 
dynamin2 as an interacting protein of NTKL, which might be responsible for the 
phenotype alterations caused by NTKL overexpression, such as cytokinesis failure, 
increased cell motility and abnormal of cell division.
INTRODUCTION
Hepatocellular carcinoma (HCC) ranks the fifth 
among the malignant cancers worldwide [1]. The molecular 
pathological mechanisms of HCC development have been 
widely studied during the last two decades. As reported by 
many studies, genomic aberrations have been frequently 
observed in HCC including gain of 1q, 6q, 8q, 17q and 20q, 
and loss of 4q, 8p, 13q, 16q and 17p have been frequently 
detected in HCC [2–5]. Among these genetic alterations, 
amplification of 1q21 is one of the most frequent changes 
in HCC and one candidate oncogene CHD1L has been 
identified [6]. The oncogenic function of CHD1L has 
been associated with its roles in inhibiting apoptosis [7], 
promoting tumor metastasis [8], and inducing resistance 
to chemotherapeutic drugs [9]. In CHD1L-transgenic 
mouse model, CHD1L could induce spontaneously tumors 
formation including HCC [10]. Recently, CHD1L has been 
shown to relocalize to DNA damage foci after DNA damage 
induction and regulate the DNA damage response [11].
As an SNF2-like family member, our previous study 
demonstrated that CHD1L could regulate expressions of 
its downstream target genes as a transcriptional factor 
[8]. Further study of the CHD1L-regulated genes would 
elucidate molecular pathogenesis of HCC. One CHD1L 
downstream target, N-terminal kinase like protein (NTKL, 
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also called Scyl1), was investigated in the present study. 
NTKL is located at 11q13 with full-length protein containing 
808 amino acids [12]. NTKL has been found to exhibit 
multiple subcellular localizations, including golgi apparatus, 
cytoplasm, centrosomes and nucleus [13]. Golgi NTKL has 
been reported to regulate golgi morphology and interact with 
Cop1 vesicles [14], while centrosome NTKL was reported 
to play a role in cell division [15]. In the present study, we 
found that NTKL, which was regulated by CHD1L, was 
frequently overexpressed in primary HCC cases. Functional 
assays showed that NTKL had strong oncogenic ability. 
Further study found that overexpression of NTKL might 
promote HCC tumorigenicity via regulating cell cycle 
progression and cell motility.
RESULTS
Expression of NTKL was regulated by CHD1L
Since our previous ChIP-based sequencing result 
suggests that CHD1L can bind to the promoter region 
of NTKL (data not shown), MatInspector was applied 
to predict potential CHD1L binding motifs within the 
promoter region of NTKL gene. Two candidate CHD1L 
binding motifs were found at upstream (˗1410~˗1400 and 
˗717~˗707) of NTKL (Figure 1A). ChIP assay was then 
used to confirm the binding of CHD1L to upstream DNA 
sequences of NTKL gene. The result showed that two 
DNA fragments NTKL-UP1 (˗858~˗675) and NTKL-UP2 
Figure 1: The CHD1L downstream target NTKL was frequently overexpressed in HCC. (A) Two candidate CHD1L binding 
motifs were found at upstream (˗1410~˗1400 and ˗717~˗707) of NTKL. The binding of CHD1L to the candidate motif sequences of NTKL 
was confirmed by ChIP assay. (B) QRT-PCR shows that overexpression of CHD1L in QGY-7703 cells could upregulate NTKL expression. 
(C) Expressions of NTKL and CHD1L were significantly correlated in 138 primary HCC samples detected by QRT-PCR. (D) NTKL expression 
was determined by QRT-PCR between tumor and corresponding non-tumor tissues in 138 HCCs, and the fold changes (RQ) was compared 
using T-test. (E) Expression of NTKL expression in primary HCCs (left) and HCC cell lines (right) was detected by Western blotting. 
(F) Kaplan-Meier survival analysis of the correlation between NTKL expression and HCC patient overall and disease free survivals.
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(˗1536~˗1338) containing CHD1L-binding motifs were 
successfully detected in ChIP products precipitated by 
CHD1L antibody (Figure 1A).
To test whether CHD1L could upregulate NTKL 
expression, CHD1L was stably transfected into HCC 
cell line QGY-7703 cells. QRT-PCR result found that 
ectopic expression of CHD1L was able to increase NTKL 
expression (Figure 1B). To further confirm the correlation 
between NTKL and CHD1L, expressions of NTKL and 
CHD1L were evaluated in 138 primary HCC samples by 
QRT-PCR. A significant correlation between expressions of 
CHD1L and NTKL (P < 0.0001) was detected (Figure 1C).
NTKL was frequently overexpressed in HCC
Since CHD1L is frequently overexpressed in 
HCC [6], the overexpression of NTKL in HCC was also 
examined by QRT-PCR in 138 HCCs. The result showed 
that the expression level of NTKL was significantly 
(P = 0.012) higher in HCC tumor tissues than that in non-
tumor liver tissues (Figure 1D). Compared with paired 
non-tumor tissue, overexpression of NTKL (defined as 
4-fold change) was detected in 24/138 (17.4%) of HCCs. 
Expression of NTKL at protein level was also checked in 
primary HCC cases and HCC cell lines by western blot 
assay (Figure 1E).
NTKL overexpression was associated with 
invasion and poor prognosis in HCC
The clinical significance of NTKL overexpression 
in this HCC cohort was then evaluated by statistic 
analysis. The results found that NTKL overexpression was 
significantly associated with vascular invasion (P = 0.012), 
suggesting that NTKL might play roles in HCC metastasis 
(Table 1). Kaplan-Meier survival analysis showed that 
overexpression of NTKL was significantly correlated 
with poorer disease-free survival of HCCs (P = 0.050, 
Figure 1F). Cox regression analysis was carried out to 
further test the effects of NTKL on the prognosis of HCC 
patients. The result showed that overexpression of NTKL 
was significantly associated with poor 3-year survival 
rates of HCC patients both in univariable (P = 0.005) and 
multivariable analysis (P = 0.033, Supplementary Table 2).
NTKL had strong tumorigenic function
To characterize the oncogenic ability of NTKL, 
full-length NTKL was cloned into expressing vector 
pCDNA3.1 and stably transfected into HCC cell lines 
QGY-7703 and MHCC-97H cells (NTKL-7703 and 
NTKL-97H). Empty vector-transfected cells (Vec-7703 
and Vec-97H) were used as controls. Ectopic expression 
of NTKL in these transfected cells was confirmed by 
Western blot analysis (Figure 2A). In vitro soft agar assay 
showed that the number of colonies formed in soft agar 
were significantly increased in NTKL-transfected cells 
(P < 0.01, student’s t test) compared with Vec-transfected 
cells in both QGY-7703 and MHC-97H cells (Figure 2B). 
To investigate the in vivo tumorigenicity of NTKL, tumor 
formation in nude mice was performed by injecting 
Vec-97H cells and NTKL-97H cells into 5 and 10 nude 
mice, respectively. After one month, tumor formations 
were detected in 2/5 and 6/10 mice induced by 
Vec-97H and NTKL-97H cells, respectively. Compared 
with xenograft tumors induced by Vec-97H cells, the 
tumor size was significantly larger in tumors induced by 
NTKL-97H cells (Figure 2C). Then xenograft tumors were 
subjected to IHC staining of NTKL and the results showed 
that NTKL overexpression could be detected in xenograft 
tumors induced by NTKL-97H cells (Figure 2D).
Overexpression of NTKL promoted G1/S 
transition
To investigate the effect of NTKL on cell cycle, 
flow cytometry was used to compare proportions of 
cells in different cell cycle phases between NTKL- and 
vector-transfected cells. As shown in he results, cells 
in G1 phase decreased, while cells in S phase increased 
in NTKL-transfected cells, compared with control cells 
(P < 0.05, student’s t test, Figure 3A). This indicated that 
overexpression of NTKL could promote G1/S cell cycle 
transition. To further confirm the results, two shRNAs 
(sh-NTKL-1 and sh-NTKL-4) specifically targeting NTKL 
were stably transfected into QGY-7703 cells. The non-
targeting scramble shRNA (sh-control) was used as a 
control. Cell cycle distribution was analyzed by flow 
cytometry. The results showed that the percentages of 
cells in G1 and S phases were significantly increased and 
decreased, respectively, in NTKL-silencing cells (P < 0.05, 
student’s t test), compared with cells treated with control 
shRNA (Figure 3B).
To further investigate the mechanisms of NTKL on 
cell cycle regulation, the effects of NTKL on cell cycle 
regulators P53 and cyclinD1 were examined by western 
blot. As shown in the results, overexpression of NTKL 
accelerated the degradation of P53, and enhanced the 
stability of cyclinD1. Conversely, knock down NTKL 
stabilized cyclinD1, and promoted the degradation of P53 
(Figure 3C). This indicated that NTKL might regulate cell 
cycle progression through affecting protein stability of 
critical cell cycle regulators.
NTKL overexpression accelerated the mitotic 
exit and chromosome segregation
In addition to the G1/S acceleration, we also 
examined the effect of NTKL on cell mitosis by real-
time imaging analysis. The time needed for chromosome 
segregation (from mitotic cell rounded up until the 
appearance of cleavage furrow) and the mitotic exit 
(from the rounded up of mitotic cells until daughter 
cells reattached) was compared among QGY7703, 
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NTKL-7703 and sh-NTKL-4 cells. The results showed 
that the average time of mitotic exit needed for NTKL-
7703 cells was much shorter than that of QGY-7703 
cells (Figure 4A). In the sh-NTKL-4 cells, the mitosis 
was rarely completed, so that mitotic exit time of 
sh-NTKL-4 cells was not included in the comparison. 
For the chromosome segregation time, NTKL-7703 also 
showed the shortest time needed, while sh-NTKL-4 cells 
showed the longest time for chromosome segregation 
(Figure 4B).
Table 1: Clinico-pathological Correlation of NTKL Expression in 138 HCCs
Clinicopathological 
features
Number (n) NTKL gene expression P*
Without 
overexpression
With overexpression
Gender
 Male 116 96(82.7%) 20(17.3%)
 Female 22 18(81.8%) 4(18.2%) 1
Age
 < 60 111 93(83.8%) 18(16.2%)
 ≥ 60 27 21(77.8%) 6(22.2%) 0.571
HbsAg†
 Negative 30 26(86.7%) 4(13.3%)
 Positive 90 72(80.0%) 18(20.0%) 0.674
Serum AFP (ng/ml)
 < 500 69 57(82.6%) 12(17.4%)
 ≥ 500 50 40(80.0%) 10(20.0%) 0.812
Tumor size(cm) ‡, §
 ≤ 5 36 32(88.9%) 4(11.1%)
 > 5 85 67(78.8%) 18(21.2%) 0.302
Cirrhosis§
 Absent 36 21(58.3%) 15(41.7%)
 Present 81 41(50.6%) 40(49.4%) 0.440
Tumor encapsulation§
 Absent 47 39(83.0%) 8(17.0%)
 Present 70 56(80.0%) 14(20.0%) 0.187
Vascular Invasion
 Negtive 71 59(83.1%) 12(16.9%)
 Micro 6 2(33.3%) 4(66.7%)
 Major 8 7(87.5%) 1(12.5%) 0.012
Tumor stage(TNM)§
 Stage I 54 46(85.2%) 8(14.8%)
 Stage II 30 24(80.0%) 6(20.0%)
 Stage III 34 27(79.4%) 7(20.6%) 0.738
*: Two–sided χ2 test;
†: Hepatitis B surface antigen;
‡: Tumor size was measured by the length of the largest tumor nodule;
§: Partial data is not available, and statistic was based on available data.
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NTKL depletion induced cytokinesis failure and 
further cell apoptosis
When we look deeper into the cell cycle altered 
by NTKL depletion by real time imaging, QGY-7703 
cells showed normal cell division. As indicated by 
yellow arrows, midbodies appeared normally after 
mitosis (Figure 4C). However, for the sh-NTKL-4 
cells, midbody formation was diminished, and cells 
stuck together long after the mitosis. Daughter 
cells could not separate far from each other, and 
cell boundaries cannot be seen clearly (Figure 4C). 
Further observations found that cytokinesis failure 
was induced in sh-NTKL-4 cells. As shown in the first 
row of Figure 4D, sh-NTKL-4 cells entered mitosis 
and finished chromosome segregation 138 minutes 
later as indicated by the cleavage furrow formation. 
However, the following cytokinesis failed as indicated 
by the re-fusion of two daughter cells (Figure 4D, first 
row). Another kind of cytokinesis failure was shown 
in the second row of Figure 4D. Two incompletely 
divided, highly synchronized cells went on a second 
round mitosis before finishing cytokinesis. Due to 
the cytokinesis failure, four daughter cells stuck 
together sharing the interconnected cytoplasm with 
separated nucleus. In addition, multipolar cell division 
was also observed in sh-NTKL-4 cells by real time 
imaging. A mitotic cell went through mitosis in the 
presence of three polars, but resulted in only two 
daughter cells (the third row of Figure 4D). All the 
above phenotypes shown in Figure 4D were rarely 
observed in the QGY-7703 cells. The increased 
percentage of polyploidy cells induced by NTKL 
depletion was further confirmed by flow cytometry 
Figure 2: NTKL had strong oncogenic function. (A) NTKL was stably transfected into HCC cell line QGY-7703 and 97H. Ectopic 
expression of NTKL was detected by Western blot. (B) Representative images of colony formation in soft agar induced by NTKL-transfected 
and Vec-transfected cells. The numbers of colonies were calculated and are depicted in the bar chart. The values indicate the mean ± SD of three 
independent experiments P < 0.001; independent Student’s t-test). (C) Control cells and two clones of NTKL overexpressing cells (NTKL-3 and 
NTKL-9) were subcutaneously injected into nude mice. Representative examples of tumors (indicated by arrows) formed in nude mice injected 
with the indicated cells. The xenograft tumor volumes were shown in the right panel. (D) IHC staining of NTKL in the xenograft tumors.
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(Figure 4E). Cytokinesis failure usually will result in 
cell apoptosis16, 17. In the present study, enhanced cell 
apoptotic index was also observed in sh-NTKL-4 cells 
compared with sh-control cells (P < 0.01, student’s 
t test) as detected by flow cytometry (Figure 4F).
Overexpression of NTKL increased cell motility
Considering the multiple localization and function 
of NTKL, we then examined whether overexpression 
or depletion of NTKL would affect cell migration and 
spreading. As shown in Figure 5A, knock down of NTKL 
significantly decreased the migration ability of HCC cells in 
wound healing assay. Cell migration and motility observed 
from the real time imaging was also analyzed by Imaris 
software. NTKL-7703 cells showed the longest migration 
distance while sh-NTKL-4 cells almost did not move at all 
during the 300 mins recorded (Figure 5B). Cell movement 
paths were shown in the lower panel of Figure 5B. The 
blue ends represented the starting points and the white 
Figure 3: Overexpression of NTKL promoted G1/S transition. (A) Flow cytometry was used to compare cell cycle distribution between 
NTKL-transfected and Vec-transfected cells. The percentages of cells at G0/G1, S and G2/M were summarized in bar charts. Data was shown as 
the mean ±SD of three independent experiments (*, P < 0.05; independent Student’s t-test). (B) Depletion of NTKL by RNAi blocked cell cycle at 
G1 phase. Data were shown as the mean ±SD of three independent experiments (*, P < 0.05; independent Student’s t-test). (C) The degradation of 
P53 and CyclinD1 was regulated by NTKL overexpression and depletion. Cells with NTKL overexpression or depletion were treated with CHX 
(50ug/mL) for time indicated to inhibit protein synthesis, and the degradation of P53 and CyclinD1 was observed by western blot.
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ends represented the ending points of cellular movement. 
We then quantitatively analyzed the cell migration by 
measuring the track displacements (the length of a straight 
line drawn from the starting to the ending point) with 
Imaris software. Results further proved the increased cell 
motility of NTKL-7703 cells as well as the reduced cell 
movements of sh-NTKL-4 cells (Figure 5B). These results 
indicated that NTKL can increase cell motility.
Figure 4: NTKL accelerated the mitotic exit and chromosome segregation. (A) Time needed for mitotic exit was compared in 
QGY-7703 and NTKL-7703 cells, results were summarized in the bar-chart (*, P < 0.05; independent Student’s t-test). (B) Time needed 
for chromosome segregation was compared among QGY-7703, NTKL-7703 and sh-NTKL-4 cells by real-time imaging analysis, and 
summarized in bar-charts (*, P < 0.05; independent Student’s t-test). (C) Representative images of cell division with indicated cells 
captured by time-lapse microscopy. Midbodies were indicated by yellow arrows. (D) Representative images of cytokinesis failure in sh-
NTKL-4 cells detected by time-lapse microscopy. (E) The percentage of polyploidy cells was detected by flow cytometry. Results were 
summairzed as the mean ±SD of three independent experiments (*, P < 0.05; independent Student’s t-test). (F) The apoptotic index was 
compared between sh-control and sh-NTKL-4 cells by flow cytometry (*, P < 0.05, independent student’s t test).
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NTKL enhanced cell motility by regulating 
F-actin reorganization
The morphological changes of NTKL overexpressing 
cells (NTKL-7703) and the NTKL depleted cells (sh-
NTKL-4) were observed under microscope (Figure 6A). 
Compared to the QGY-7703 cells, NTKL-7703 cells 
showed a relatively more flattened morphology, while 
sh-NTKL-4 cells showed a rounded-up look. Cell areas 
of QGY-7703, NTKL-7703 and sh-NTKL-4 cells were 
quantitatively measured by image J. As indicated by the 
bar chart, the average cell area of NTKL-7703 was much 
larger than QGY-7703 cells, which was in accordance 
with the morphological observation. The sh-NTKL-4 
cells showed the smallest cell area among the three cells 
(Figure 6A). Interestingly, elongated actin bundles were 
only observed in NTKL-7703 cells, but not in QGY-
7703 and sh-NTKL-4 cells (Figure 6B), suggesting that 
NTKL could induce actin reorganization. We next stained 
the F-actin of the 3 groups of cells with rhodanmin-
conjugated phalloidin to study the reorganization of 
F-actin bundles. Increased protrusion structures such as 
philopodia and lamelipodia were observed in NTKL-7703 
cells, compared with parental QGY7703 cells (Figure 6B). 
In sh-NTKL-4 cells, F-actin staining was reduced and no 
protrusion structures were observed (Figure 6B). Since the 
small GTPases Rac1/cdc42 plays important roles in the 
formation of philopodia and lamelipodia (20), expression 
level of phosphorylated Rac1/cdc42 in sh-NTKL-1 and sh-
NTKL-4 cells was checked by western blot. The results 
showed that level of phosphorylated Rac1/cdc42 was 
decreased in NTKL depleted cells compared with sh-
control cells (Figure 6C). These findings suggested that 
overexpression of NTKL can facilitate philopodia and 
lamellipodia formation through regulating actin nucleation 
and phosphorylation of Rac1/cdc42.
NTKL interacted with Dynamin2
In order to identify molecular mechanism of 
NTKL in regulating cell division and cell motility, 
co-immunoprecipitation assay was carried out using 
NTKL antibody as the bait, with rabbit IgG as negative 
control to identify interacting proteins of NTKL. Protein 
mixtures pulled down by NTKL antibody and IgG were 
then subjected to SDS electrophoresis. Specific bands 
showed in the experimental group but not in the control 
group were cut out and analyzed by mass spectrometry. 
Four potential NTKL-interacting proteins including 
Dynamin2, granulin, keratin and β-actin were pulled 
down by NTKL antibody (Figure 6D). Among these 
potential interacting proteins, Dynamin2 attracted our 
attention, for previous study showed that Dynamin2 
might coordinate membrane remodeling and actin 
filament dynamics during cell morphogenesis and cell 
migration [18]. In addition, Dynamin2 has been localized 
to midbodies during cytokinesis [19]. The interaction 
between NTKL and Dynamin2 was further confirmed by 
co-immunoprecipitation assay (Figure 6E). Furthermore, 
we observed that NTKL and Dynamin2 co-localized with 
Figure 5: NTKL increased cell motility. (A) Cell migration ability of sh-Control, sh-NTKL-1 and sh-NTKL-4 cells were detected by 
wound healing assay. *P < 0.05, independent student’s t test. (B) Six to seven cells in one area of QGY-7703, NTKL-7703 and sh-NTKL-4 
cells were observed for the migration analysis. Imaris software was applied for locating the center of each nucleus for the drawing of cell 
track in 300mins. Upper panel showed the cells in each group captured at the start point. Lower panel showed cell track that record the paths 
cells moved (blue ends, starting points; white ends, ending points). Track displacement of each cell was shown in bar chart.
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each other during cytokinesis by immunofluorescence 
staining (Figure 6F). These results indicated that the 
interaction between NTKL and Dynamin2 might be 
important for NTKL in regulating cell cytokinesis and 
cell motility. Further characterization of Dynamin2 might 
help elucidate the molecular mechanism of NTKL in 
tumorigenesis.
DISCUSSION
Overexpression of CHD1L is one of the most 
frequent genetic alterations in HCC. The oncogenic 
function of CHD1L has been correlated with its 
upregulating downstream target genes such as ARHGEF9 
[8], TCTP [21], and SPOCK1 [22]. In this study, we 
Figure 6: NTKL regulated the reorganization of actin cytoskeleton and interacted with dynamin2. (A) Representative 
images showing the morphology of QGY-7703, NTKL-7703 and sh-NTKL-4 cells. The cell areas were measured by image J and results 
were summarized in the bar chart (*, P < 0.05, **, P < 0.001). (B) Invasive structures (yellow arrows) composed of actin filaments were 
found in NTKL-7703 cells, but not in QGY-7703 and sh-NTKL-4 cells. Phalloidin staining indicated F-actin organization in QGY-7703, 
NTKL-7703 and sh-NTKL-4 cells. (C) Reduced p-Rac1/cdc42 was detected in NTKL depleted cells by Western blotting. (D) Results of 
Co-IP assay using NTKL and IgG (control) antibodies. Proteins recognized by mass spectrometry were indicated. (E) Interaction between 
NTKL and dynamin2 was confirmed by Co-IP assay using NTKL and dynamin2 antibodies. N, NTKL; D, dynamin2. (F) Colocalization of 
NTKL and dynamin2 was confirmed by immunofluorescence staining.
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characterized another CHD1L regulated gene NTKL for its 
role in the development and progression of HCC. Our data 
showed that overexpression of CHD1L could upregulate 
the expression of NTKL in HCC cell lines. ChIP assay 
confirmed the binding of CHD1L to the promoter region 
of NTKL. In addition, expression of NTKL in HCC clinical 
samples was significantly correlated with that of CHD1L 
(P < 0.0001). All these results implied that NTKL might be 
a downstream target of CHD1L. Overexpression of NTKL 
was detected in 17.4% of HCCs, which was significantly 
associated with vascular invasion and poorer prognosis. 
Cox regression analysis showed that overexpression 
of NTKL was an independent factor for predicting poor 
3-year survival of HCC patients (P = 0.033).
In vitro and in vivo functional studies found that 
NTKL had strong tumorigenic ability. Mechanism study 
found that overexpression of NTKL could accelerate G1/S 
transition, and the effect could be reversed by NTKL 
depletion. Although the exact mechanism of NTKL 
promoting cell cycle progeression was not clear, the 
accelerated degradation of P53 induced by NTKL would 
help explain the phenotype to some extent. In our previous 
study, we found that SCYL1BP1 (also called NTKL-BP1), 
a NTKL binding protein, could inhibit the Pirh2-mediated 
degradation of P53 [23], although the exact role of NTKL 
in this event has not been fully explored.
Another interesting finding of this study is that 
NTKL could accelerate the mitotic exit and chromosome 
segregation. The catalytic activity of Cdk1 is necessary 
and sufficient for maintaining the mitotic state of cells, 
and decreasing Cdk1 activity is the major factor to drive 
the exit of cells from mitosis [24]. One recent study finds 
that decreasing Cdk1 activity in mitosis causes a faster 
mitotic exit [25]. Using co-IP assay, we pulled down 
several potential NTKL-interacted proteins including 
dynamin2. Since the inhibition of dynamin2 can induce 
cytokinesis failure [26], dynamin2 might be involved 
in the regulation of mitosis [27]. Just like the results of 
inhibition of dynamin2, we found that depletion of NTKL 
could induce the cytokinesis failure, which subsequently 
led to the re-fusion of daughter cells and multipolar cell 
division, and finally triggered the apoptosis.
Dynamin2 has been reported to participate to the 
regulation of actin filament assembly, filament stability 
and filament remodeling [28], which is related with many 
important process including cellular movements and cell 
division. Actin protein was translated as protein monomer 
called G actin, and G actin needs to be assembled into 
F-actin to function in cell movement and other process, 
and the process of this actin assembly was called actin 
nucleation [29]. Dynamin2 takes part in actin nucleation 
by taking the hat off actin filaments to allow actin 
monomer to be assembled to the end of the actin filament 
thus resulted in the elongation of F-actin [29]. Two cellular 
structures related with F-actin assembly are filopodia and 
lamelipodia [30], which are frequently reported to form 
during epithelial-mesenchymal transition (EMT), and 
associated with tumor cell motility [31]. Dynamin2 has 
been also correlated with the degradation of extra cellular 
matrix at the front of protrusion [32]. In the present study, 
we found that overexpression of NTKL could increase 
cell motility by regulating F-actin reorganization. Actin 
nucleation was attenuated in NTKL depleted cells by the 
evidence of reduced F-actin staining. Downregulation of 
phosphorylated Rac1/cdc42 was also observed in NTKL 
depleted cells in accordance with previous report [20], 
that p-Rac1/cdc42 took part in the F-actin reorganization. 
Due to the fact that dynamin2 takes part in all the process 
mentioned above (e.g. cytokinesis, cell movements, 
actin nucleation and mitosis), and NTKL interact with 
dynamin2, we hypothesize that NTKL regulated cell 
motility, cytokinesis, actin assembly and mitosis through 
interacting with dynamin2. Further study is needed to 
fully understand the interaction among CHD1L, NTKL 
and dynamin2, as well as their roles and molecular 
mechanisms in the development and progression of HCC.
MATERIALS AND METHODS
Cell lines and tumor specimens
Human immortalized liver cell lines LO2, QSG-
7701 and HCC cell lines, SMMC-7721, QGY-7703, 
CRL-8064 and MHCC-97H used in this study have been 
described in previous studies [7–9]. A total of 138 HCC 
patients, who underwent hepatectomy for HCC at Sun 
Yat-Sen University Cancer Center (Guangzhou, China), 
were included in this study. Human tissue samples used in 
this study were approved by the Committees for Ethical 
Review of Research involving Human Subjects at Cancer 
Center of Sun Yat-Sen University.
Antibodies and western blotting
Western blot analyses were performed with the 
standard protocol. Antibodies for NTKL, dynamin2, 
p53, GAPDH, cyclinD1, phosphorylated threonine and 
β-actin were purchased from Abcam (Abcam, Cambridge, 
UK). Antibody for CHD1L was purchased from Genway 
(Genway Biotech, San Diego, CA). Antibodies for 
phosphor-Rac1/cdc42 were purchased from cell signaling 
(Cell Signaling Technology, Beverly, CA). Letin-88 and 
rhodanmine-phalloidine were purchased from Sigma-
Aldrich (Sigma-Aldrich, St. Louis, MO).
RNA extraction and quantitative real-time PCR
Total RNA was extracted using TRIzol Reagent 
(Invitrogen, Carlsbad, CA), and reverse transcription was 
performed using an Advantage RT-for-PCR Kit (Clontech 
Laboratories, Mountain View, CA, USA) according to the 
manufacturer’s instructions. For qRT-PCR analysis, cDNA 
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was amplified using a SYBR Green PCR Kit (Applied 
Biosystems, Foster City, CA) and an ABI PRISM 7900 
Sequence Detector. Sequences of primers used in this 
study were listed in Supplementary Table 1. The relative 
fold change of NTKL was defined as fold increase of 
NTKL expression in the tumor tissues compared with their 
paired non-tumor tissues. The average fold increase of 
NTKL expression in HCC cases with NTKL up-regulation 
was 3.96, thus the threshold of 4-fold was chosen to define 
an overexpression in further analysis.
Establishment of NTKL overexpressing and 
depleted cells
Full-length of NTKL was cloned into PCDNA3.1 and 
stably transfected into QGY-7703 (NTKL-7703) and MHC-
97H cells (NTKL-97H) using lipofectamine2000 (Origene, 
Rockville, MD). Empty vector-transfected cells (Vec-7703 
and Vec-97H) were used as controls. NTKL depleted cells 
were established by stably transfecting shRNA targeting 
NTKL (Origene, Rockville, MD) into QGY-7703 cells.
Chromatin immunoprecipitation (ChIP)
The chromatin immunoprecipitation experiment 
was performed using an EZ-Magna ChIPTM G kit (Upstate 
Biotechnology, Lake Placid, NY) according to previous 
studies [8].
In vitro oncogenic assays
Cell growth rate was assessed by XTT kit (Roche 
Diagnostics, Indianapolis, IN), and colony formation in 
soft agar were carried out as described previously [6–8]. 
Both experiments were repeated independently in 3 times.
Tumor xenograft mouse model
NTKL-97H and Vec-97H (4 × 106) were subcu-
taneously injected to five-week-old nude mice (10 mice for 
NTKL-97H and 5 mice for Vec-97H), respectively. Tumor 
formation in nude mice was checked after 4 weeks. All 
animal experiments were done according to institutional 
standard guidelines in the Committee on the Use of Live 
Animals in Teaching and Research (CULATR) of the 
University of Hong Kong.
Flow cytometry
Cells of 70~80% confluence were digested into 
single cell suspension, fixed in 70% ethanol, stained with 
propidium iodide (PI), and analyzed by flow cytometry. The 
results were analyzed with Modfit and Cell Quest software.
Immunohistochemistry staining (IHC)
Tissue slides were dewaxed and dehydrated 
according to standard protocol. Antigen retrieval was 
done by boiling slides in antigen retrieval buffer for 
15mins. Primary antibody was added onto the section 
and incubated at 4°C overnight. Secondary antibody was 
added for 1 hr after rinsing by PBS. DAB was used for 
staining.
Co-immunoprecipetation and mass spectrometry 
analysis
CoIP assay was carried out according to manufacturer’s 
instruction (Roche, Mannhein, Germany). Briefly, lysis 
buffer was added to NTKL-7703 cells and total protein was 
extracted by centrifuge. IgG or indicated antibodies were 
added into cell lysate and incubated for 1 hr on a rocking 
platform at 4°C, followed by addition of protein agarose G 
and incubation overnight. After washing, protein loading dye 
was added into protein agarose G containing the pulled down 
product and boiled at 100°C for 3 mins and subjected to SDS 
gel electrophoresis. After silver staining, bands appearing 
in the experimental group was cut off and sent for mass 
spectrometry analysis.
Immunofluorescence (IF)
IF staining was performed as described previously 
(8). Briefly, cells seeded on cover slips were fixed by 4% 
paraformaldehyde and incubated with the indicated antibody 
overnight at 4°C. After washing, Texas-red or FITC 
conjugated secondary antibody was added to the cells and 
incubated for 1 hr. After washing, cells were counterstained 
with DAPI (Vector Laboratories, Burlingame, CA) and 
observed under a fluorescence microscope. For F-actin 
staining, after fixation as above, cells were stained with 
Rhodamine phalloidin (Invitrogen) for 30 mins.
Realtime imaging
Cells were seeded onto 5-cm diameter CELL 
view dishes (Greiner Bio-One GmbH, Frickenhausen, 
Germany). Cell migration and cell cycle progression 
were observed under Perkin Elmer Spinning Confocal/
Widefield Imaging system (Perkin Elmer, Waltham, MA). 
Time-lapse images were taken every 3 or 5 minutes for 
48 hours with a 40 × objective lens. Cell migration was 
analyzed by Imaris software.
Statistical analysis
The SPSS statistical package for Window version 
13 (SPSS, Chicago, IL) was used for data analysis. RQ 
of NTKL in tumor and nontumor samples were compared 
using paired sample T-test. The survival curves of patients 
with or without NTKL upregulation was derived by 
Kaplan-Meier method. The correlation between clinical 
features of HCC patients and NTKL upregulation was 
carried out by Pearson χ2 test. A P value less than 0.05 
was considered statistically significant.
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